The density of immunoglobulin (Ig) on the surface of mouse bone marrowderived (B) lymphocytes has recently been studied by two groups of investigators (1) (2) (3) . Both groups attributed developmental significance to differences in the density of Ig on the surface of these cells, but Osmond and Nossal concluded that a substantially greater heterogeneity in the amount of Ig per B cell existed in the immature population vs. the mature population, whereas Sidman and Unanue indicated that immature cells have, on the average, more Ig than mature cells. The techniques employed in these studies are very tedious and are, therefore, poorly suited to a detailed analysis of the distribution of the density of surface Ig on different populations of B lymphocytes. However, the density of surface Ig on individual B lymphocytes derived from different sources is critical to the understanding of antigen-B-lymphocyte interaction and activation. The introduction of the technique of rapid flow microfluorometry (RFMF) ~ and electronic cell sorting makes possible a direct approach to the study of surface Ig density on B lymphocytes and to an evaluation of its developmental and functional significance.
Using this technology, we report here the identification among splenic B lymphocytes of a large subpopulation of cells possessing a relatively low-tointermediate density of surface Ig when a fluorescein-conjugated (F1) antimouse Ig or anti-K is used to detect Ig-bearing cells. Such B lymphocytes, as 
Materials and Methods
Animals. DBA/2N, C57BL/6N, and BALB/cAnN (germfree or conventionally reared) mice were obtained from the Animal Production Section, Division of Research Services of the National Institutes of Health, Bethesda, Md. CBA/J and C3H/HeJ mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. BALB/c nu/nu and +/nu littermates which were in the seventh backcross generation were obtained from the Charles River Breeding Laboratories, Inc., Wilmington, Mass. Mice were from 8 to 12 wk of age at the time of study unless otherwise noted. In all instances, lymphoid organs from individual mice were studied, except when newborn to 3-wk-old mice were analyzed, when the lymphoid organs of four to five individual mice were pooled.
Cell Suspensions. Spleens; Peyer's patches; popliteal, inguinal, and cervical lymph nodes; and tibiae and fibulae were obtained from mice killed by cervical dislocation. Suspensions of spleen, Peyer's patches, and lymph node cells were prepared by teasing of these organs with forceps into RPMI 1640 (Grand Island Biological Co., Grand Island, N. Y.) while bone marrow cells were flushed from the shaft of the tibia or fibula using a 25 gauge needle and syringe. Cell aggregates were dispersed by passage through a 26 gauge needle. Spleen and bone marrow cells were centrifuged at 100g for 10 min, the supernatant fluid removed, and the pellet treated with 5 ml of 0.83% ammonium chloride at 4°C for 5 rain to lyse red blood cells. Nucleated cells obtained by this method were washed through fetal calf serum (FCS) (Grand Island Biological Co.) to remove red blood cell ghosts.
Anti-Immunoglobulin Reagents.
A polyspecific goat anti-mouse 7S globulin and an antimouse-/z were obtained from Meloy Laboratories Inc., Springfield, Va. (Lot nos. 40691 and 40643, respectively). These antisera were digested with 2% (wt/wt) pepsin (Mann Research Labs, New York) in acetate buffer (pH 4.0) for 18 h, and F(ab')2 fragments were further purified on a Sephadex G-200 column (100 x 1 cm), dialyzed against a bicarbonate buffer (pH 9.3), and concentrated to 4 mg/ml. F(ab')2 fragments were conjugated with fluorescein isothiocyanate (BBL, Division of Becton, Dickinson & Co., Cockeysville, Md.) by overnight dialysis of 10 ml of protein (10 mg) in a bicarbonate buffer (pH 9) against 1 mg of FITC in 1 ml of the buffer enclosed within a dialysis bag. F1 F(ab')2 antisera with a molar ratio of protein to fluorescein of approximately 2:1 were isolated from proteins with a higher or lower protein-to-fluorescein ratio using DEAEcellulose column chromatography. The F1 F(ab')2 anti-Ig and anti-/z will be referred to as the F1 anti-Ig and F1 anti-/~, respectively. In addition to these preparations, a series of fluoresceinated affinity column-purified antibodies was also used in these studies. These include goat anti-mouse Y~-, y2-, a-, and/z-antibodies (4) and rabbit anti-mouse-K antibody (a gift from Dr. R. Mage, NIH, Bethesda, Md.).
In order to further analyze the specificity of the F1 anti-Ig, 0.8 mg (0.2 ml) of this reagent was passed through a 1 ml column containing 200/zg each of IgGj(K), IgG~a(K), and IgG2b(K) myeloma proteins bound to Sepharose. The column was eluted with 5 cm 3 of borate buffer and the effluent was dialyzed against saline and concentrated to the original protein concentration. The molar ratio of protein to fluorescein of this material was similar to that of the original. As noted in the Results section, absorption of the anti-Ig with these three mouse myeloma proteins abolished the ability of this antisera to stain mouse spleen cells. In order to further characterize the F1 anti-Ig, we stained C57BL/6 spleen cells with this reagent and compared the profile to that of C57BL/6 stained cells stained with F1 anti-K. The fluorescence profiles of these cells after labeling with either F1 anti-Ig or F1 anti-K were virtually identical and the frequency of Igpositive cells were 44.7 and 46.5%, respectively. Moreover, after absorption of the F1 anti-Ig on a Sepharose column containing IgG1, IgG2a, and IgG2b mouse myeloma proteins, as described in the Materials and Methods section, its capacity to label splenic B lymphocytes was abolished.
The large number of splenic B lymphocytes displaying a low-to-intermediate degree of their volume and density of surface Igo In order to distinguish between these possibilities, spleen cells from DBA/2N mice were stained with F1 anti-Ig (Fig.  2a) and cells with low fluorescence intensity were separated from those with high fluorescence intensity using the FACS (Fig. 2 b) . When these cells were re-examined with the FACS, the separation of low from high intensity fluorescence cells was confirmed (Fig. 2 c) . The average cellular volumes of these two populations were 119 and 128 ~m 3 for the "bright" and low-to-intermediate fluorescence intensity B lymphocytes, respectively. This indicates that the distinct fluorescence intensities of these two populations does not reflect differences in their cellular volumes, but is secondary to differences in the density of Ig on their surfaces.
Fluorescence Profiles of Bone Marrow, Lymph Node, or Peyer's Patch Lymphocytes Stained with Fl anti-K. The fluorescence profiles of bone marrow, lymph node, and Peyer's patch lymphocytes stained with F1 anti-K are shown in Figs. 3a-c, respectively . In order to facilitate the comparison of these profiles with those obtained with splenic lymphocytes, the scale (counts × 100) of the bone marrow, lymph node, and Peyer's patch plots was changed so that the areas under the Ig-positive portion of the curves (channels 80-1,000) would equal that of the splenic profile and the two profiles were plotted together. The frequency of Ig-positive cells in the bone marrow, lymph nodes, and Peyer's patches was 18.9, 18.4, and 55.2%, respectively. B lymphocytes derived from CBA/J lymph nodes (Fig. 3 b) had a fluorescence profile which was very similar to the profile of splenic B lymphocytes. The profile obtained with Peyer's patch cells (Fig. 3c) demonstrates that a large fraction of the cells have a very low fluorescence intensity and are poorly separated from background. No fluorescence peak was seen when bone marrow cells (Fig. 3a) were labeled with F1 anti-K. Moreover, there were substantial numbers of very intensely stained B lymphocytes in bone marrow, and the relative frequency of bright cells in this organ was greater than in spleen.
Fluorescence Profile of Neonatal Spleen Cells Stained with Fl Anti-Ig. The absence of the fluorescence peak among bone marrow cells stained with F1 antiIg suggested that the cells within the low-to-intermediate fluorescence peak seen in the spleens and lymph nodes of adult mice represented a mature subpopulation of B lymphocytes. This was further studied by examining the fluorescence profile of spleen cells derived from 3-, 10-, 17-, and 30-day-old and adult BALB/c mice (Figs. 4a-e) . In the first 17 days of life, the relative frequency of cells with a very low-to-low (channels 80-200) and low-to-intermediate (channels 200-400) fluorescence intensity among the Ig-positive cells (channels 80-1,000) increases so that at 17 days they represent 44.2 and 42.1% of the Ig-positive cells, respectively (Table I) . These changes are associated with a marked increase in the overall frequency of Ig-positive cells (29.2 to 54.0%). After 17 days, the frequency of cells with a very low-to-low fluorescence intensity begins to decrease and the continued decline in this population associated with an increase in the relative frequency of cells with a low-to-intermediate fluorescence intensity results in the characteristic F1 anti-Ig-labeled adult profile (Fig. 4 e) . F1 anti-Ig were also similar to each other and to that of normal adult cells (Fig.   5 ). However, the frequency of Ig-positive cells in BALB/c nu/nu spleen cell suspensions was considerably greater (87.1%) than seen with the +/nu spleens (5O.6%).
Fluorescence Profiles of nu/nu and Germfree BALB/c Splenic B Lymphocytes

Fluorescence Profiles of Lymphocytes Stained with Fl Anti-Heavy Chain
Antibodies. The frequency of fluorescent cells after labeling adult CBA/J spleen cells with F1 anti-Ti, F1 anti-72, F1 anti-a, and F1 anti-g was <1, 3.8, <1, and 54.0%, respectively. Although the F1 anti-g stained an equivalent percentage of spleen cells when compared to F1 anti-K (54 vs. 54.1%), a fluorescence peak was not seen after labeling with F1 anti-g (Fig. 6a) .
When B lymphocytes from CBA/J adult bone marrow, lymph node, and Peyer's patches were stained with F1 anti-g, the profiles obtained were generally similar to each other and to those observed with adult spleen cells (Figs.  6b-d) . In no case, was a low-to-intermediate intensity fluorescence peak observed. However, the relative frequency of cells with a very low-to-intermediate density of surface IgM among the Ig-positive cells was greater in lymph node and Peyer's patches (86.0 and 89.4%, respectively) than spleen and bone marrow (74.2 and 71.7%, respectively). The frequency of Ig-positive lymphocytes, detected after labeling with F1 anti-g, was 19.8, 16.6, and 33.8% when cells derived a low-to-intermediate density of total surface Ig. Moreover, since F1 anti-T2 antibody labeled only 3.8% of splenic lymphocytes, it is unlikely that cells bearing passively acquired cytophilic antibody of the IgG2 class contribute to any extent to this peak. The characteristic profile observed after labeling adult spleen cells with Fl anti-Ig was also seen when adult spleen cells derived from either nu/nu mice or from mice reared under germfree conditions were examined. Thus, the development of the large, relatively homogenous population of splenic B lymphocytes, which have a low-to-intermediate density of surface Ig, appears to be independent of either antigenic stimulation or T-lymphocyte cooperation. Moreover, the absence of the low-to-intermediate fluorescence peak among adult bone marrow cells and neonatal spleen cells and its presence in adult spleen and lymph node cells suggest that the cells with a low-to-intermediate density of surface Ig represent a distinct, mature subclass of B lymphocytes.
The fluorescence profiles of F1 anti-/~-labeled cells derived from adult mouse bone marrow, adult spleen, or neonatal spleen lacked the peak seen when F1 anti-Ig-labeled adult spleen cells were examined. Nonetheless, a clear difference in the fluorescence profiles of F1 anti-/~-labeled adult and neonatal spleen was noted. On the other hand, the F1 anti-~ profiles of adult bone marrow and adult spleen were not distinguishable. Thus, the relative immaturity of adult bone that of unlabeled cells and which might not be detected as Ig-positive cells using conventional microscopy. This is not an important problem with F1 anti-Ig-or F1 anti-K-labeled spleen or lymph node cells because the relative frequency of cells with a very low level of fluorescence intensity is quite low. However, such cells represent a larger fraction of cells labeled by F1 anti-~. On the other hand, we did observe a large difference in the frequency of cells labeled by Fl anti-K and by F1 anti-~t in Peyer's patch cell suspensions, as has been previously reported by Guy-Grand and his co-workers (7) . A number of observations suggest that the development of the peak of splenic B lymphocytes is associated with the acquisition by these cells of the surface membrane protein which is the putative homologue of human surface IgD (subsequently referred to as IgD) (8) . The appearance of the adult splenic F1 anti-Ig-labeled fluorescence profile and of an adult ratio of surface IgM to IgD occurs after the first 30 days of life and their development is seen in both germfree and nu/nu mice. In addition, the differences between the profiles of F1 anti-Ig-labeled bone marrow and spleen, and the similarities seen after labeling these cells with F1 anti-~ can be best explained by the absence of surface IgD on the surface of bone marrow cells, as noted by Vitetta et al. (8) . The decrease in the fraction of F1 anti-Ig-labeled very-low-to-low fluorescence intensity cells and the increase in the frequency of F1 anti-~-labeled very-low-to-low fluorescence intensity cells in developing mice is, therefore, most likely due to the acquisition of surface IgD by maturing splenic B lymphocytes which bear very-low-to-low densities of surface IgM.
It is not clear from our data if a population of B lymphocytes that exclusively expresses IgD exists in lymph node or spleen. However, if such a population is present in these organs, then it must represent a relatively small fraction of Igbearing B lymphocytes, as the frequency of IgM-positive cells was only slightly less than that of cells detected with F1 anti-Ig. It is possible that a population of B lymphocytes exists with a relatively high IgD-to-IgM ratio but which still bears sufficient IgM to be detected by the FACS. Of course, unanticipated crossreactions between IgM and IgD may exist and may lead to an overestimate of the relative frequency of IgM-bearing cells. In Peyer's patches, on the other hand, there may be a substantial number of cells which bear IgD only.
The development of a large population of splenic B lymphocytes with a low-tointermediate density of surface Ig also coincides temporally with the acquisition of the antigens responsible for the minor lymphocyte-stimulating (Mls) mixed lymphocyte reactions and the appearance of complement receptor lymphocytes (9, 10) . These data indicate that the development of Mls-defined antigens, the complement receptor, surface IgD, and large numbers of lymphocytes with a low-to-intermediate density of surface Ig serve as markers of a mature subpopulation of B lymphocytes. Moreover, they show that the acquisition of immunocompetence by B lymphocytes is not simply a function of expression of large amounts of immunoglobulin on the cell membrane.
Summary
The density of total Ig and of IgM, IgGl, IgG2, and IgA on the surface of adult murine splenic B lymphocytes was measured using the technique of rapid flow microfluorometry. In addition, the density of total surface Ig and of IgM on B lymphocytes derived from adult bone marrow, lymph nodes, and Peyer's patches, and from neonatal spleen was determined. Adult spleen and lymph node B lymphocytes are characterized by the presence of a large population of cells with a low-to-intermediate density of total surface Ig, which is seen as a peak in the fluorescence profiles when these cells are labeled with fluoresceinconjugated (F1) anti-Ig. This peak is not detected when neonatal spleen or adult bone marrow are examined; the development of this peak among spleen cells occurs during the first 4 wk of life. Although the characteristic fluorescence intensity peak is not seen when adult spleen cells are labeled with F1 anti-~, changes in the density of surface IgM do occur during the first few weeks of life and are detected as a decrease in the frequency of cells which have relatively large amounts of surface IgM. The differences seen in the fluorescence patterns of adult spleen cells labeled with F1 anti-Ig and F1 anti-~ may be due to the appearance of IgD on the surface of mature splenic B lymphocytes. This is supported by the similarity of the fluorescence profiles of adult bone marrow cells stained with F1 anti-Ig and F1 anti-~, as the latter population of cells is reported to lack surface IgD.
